array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Regeneron Pharmaceuticals Inc" ["slug"]=> string(38) "c469a-us-regeneron-pharmaceuticals-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77" ["description"]=> string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. " ["address_street"]=> string(25) "777 Old Saw Mill River Rd" ["address_place"]=> string(9) "Tarrytown" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1988-02-08" ["website_domain"]=> string(13) "regeneron.com" ["website_url"]=> string(25) "https://www.regeneron.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(10368) ["article_count"]=> int(2748) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(59) "Regeneron: a new protagonist in the Italian oncology sector" ["snippet_en"]=> string(294) "Regeneron is a biotech company that recently appeared on the Italian scene, but a world leader in biotechnology. Founded in 1988 by two scientists, it is dedicated to the development of innovative drugs and monoclonal antibodies for which it has developed a cutting-edge platform exploiting the" ["url"]=> string(118) "https://www.pharmastar.it/pharmastartv//business/regeneron-un-nuovo-protagonista-nel-settore-oncologico-italiano-13311" ["image_url"]=> string(78) "https://images.businessradar.com/articles/22d4323b-afd5-41bd-84c9-fd568cfeea79" ["source"]=> string(13) "pharmastar.it" ["publication_date"]=> string(10) "2024-10-23" ["categories"]=> array(3) { [0]=> string(14) "Product Launch" [1]=> string(5) "Fraud" [2]=> string(5) "R & D" } } [1]=> array(7) { ["title_en"]=> string(63) "Exploring Regeneron's Future: Innovations and Market Strategies" ["snippet_en"]=> string(147) "Discover the innovative strategies and market challenges faced by Regeneron Pharmaceuticals as it seeks to enhance growth and navigate competition." ["url"]=> string(98) "https://investorshangout.com/exploring-regenerons-future-innovations-and-market-strategies-46733-/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5e6fb2c2-1996-4025-8d52-9513e6fe7118" ["source"]=> string(20) "investorshangout.com" ["publication_date"]=> string(10) "2024-09-30" ["categories"]=> array(4) { [0]=> string(11) "Competition" [1]=> string(15) "Market Movement" [2]=> string(21) "Competitive Behaviour" [3]=> string(5) "R & D" } } [2]=> array(7) { ["title_en"]=> string(97) "Michal Lajčiak won the global competition, he wants to use robots in the factories of the future" ["snippet_en"]=> string(253) "High school student Michal Lajčiak won the global science and technology competition for high school students in the robotics and intelligent machines category. The Regeneron ISEF 2024 competition is the most prestigious event of its kind in the world." ["url"]=> string(115) "https://dennikn.sk/4045178/michal-lajciak-zvitazil-v-celosvetovej-sutazi-roboty-chce-vyuzit-v-tovarnach-buducnosti/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b9b86613-b45b-4161-8b78-52dfc36157db" ["source"]=> string(10) "dennikn.sk" ["publication_date"]=> string(10) "2024-06-14" ["categories"]=> array(4) { [0]=> string(17) "Academic Research" [1]=> string(11) "Competition" [2]=> string(5) "Event" [3]=> string(5) "R & D" } } [3]=> array(7) { ["title_en"]=> string(70) "The Greek head of the research on the corona virus vaccine in New York" ["snippet_en"]=> string(205) "Dr. Christos Kyratsous, vice president and head of infectious disease and vector technologies research at Regeneron is leading the coronavirus vaccine research in New York. The 39-year-old scientist, the.." ["url"]=> string(119) "https://www.ellines.com/erga-ellinon/48118-o-ellinas-epikefalis-tis-ereunas-gia-to-embolio-tou-koronoiou-sti-nea-yorki/" ["image_url"]=> NULL ["source"]=> string(11) "ellines.com" ["publication_date"]=> string(10) "2024-05-21" ["categories"]=> array(3) { [0]=> string(17) "Academic Research" [1]=> string(8) "Epidemic" [2]=> string(5) "R & D" } } [4]=> array(7) { ["title_en"]=> string(84) "Collaborating with the Industry is Essential for the Future of Research: David Garza" ["snippet_en"]=> string(110) "Tec Science Summit, a day focused on science, innovation and technology at the Tec de Monterrey, begins today." ["url"]=> string(78) "https://tecscience.tec.mx/en/human-social/tec-science-summit-2024-inaguration/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/55b3396c-9bcc-45f4-86db-abc207064f2d" ["source"]=> string(6) "tec.mx" ["publication_date"]=> string(10) "2024-02-28" ["categories"]=> array(2) { [0]=> string(6) "Merger" [1]=> string(5) "R & D" } } [5]=> array(7) { ["title_en"]=> string(91) "Artificial Intelligence Successfully Predicts Price Trend Of Viking Therapeutics And NVIDIA" ["snippet_en"]=> string(100) "( VIANEWS)– The Innrs Artificial Intelligence algorithm has been making predictions about the next" ["url"]=> string(113) "https://via.news/2023/12/13/artificial-intelligence-successfully-predicts-price-trend-viking-therapeutics-nvidia/" ["image_url"]=> NULL ["source"]=> string(8) "via.news" ["publication_date"]=> string(10) "2024-02-13" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(5) "R & D" } } [6]=> array(7) { ["title_en"]=> string(55) "Regeneron to acquire 2seventy’s cell therapy pipeline" ["snippet_en"]=> string(155) "About 150 of the smaller company's employees will also transition to Regeneron, which is setting up a new cellular medicines research and development unit." ["url"]=> string(92) "https://www.biopharmadive.com/news/regeneron-2seventy-cell-therapy-pipeline-purchase/705955/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7b5bbe9c-6a35-4db8-89ff-fcbfbdc585e0" ["source"]=> string(17) "biopharmadive.com" ["publication_date"]=> string(10) "2024-01-30" ["categories"]=> array(2) { [0]=> string(11) "Acquisition" [1]=> string(5) "R & D" } } [7]=> array(7) { ["title_en"]=> string(66) "Scientific society honors Augusta Prep student for kidney research" ["snippet_en"]=> string(149) "Science has always fascinated Emily Huo. What she helped find about kidney function puts her among the world's most prestigious high school scholars." ["url"]=> string(159) "https://www.augustachronicle.com/story/news/education/2024/01/18/scientific-society-honors-augusta-prep-student-for-kidney-research-regeneron-stem/72261370007/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ae2cbb99-0b02-4532-a9e7-ae351da6a8f8" ["source"]=> string(20) "augustachronicle.com" ["publication_date"]=> string(10) "2024-01-18" ["categories"]=> array(4) { [0]=> string(17) "Academic Research" [1]=> string(11) "Competition" [2]=> string(5) "Award" [3]=> string(5) "R & D" } } [8]=> array(7) { ["title_en"]=> string(38) "Market Trends Report 2023: Shohta Ueno" ["snippet_en"]=> string(80) "Ueno of Regeneron talks about strategy for the unitary patent and UPC litigation" ["url"]=> string(94) "https://www.managingip.com/article/2clb9fgrsvbx3uwszx2x2/market-trends-report-2023-shohta-ueno" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1b85bda3-9e73-4d4d-b70f-4b038b46c130" ["source"]=> string(14) "managingip.com" ["publication_date"]=> string(10) "2023-12-18" ["categories"]=> array(6) { [0]=> string(21) "Competitive Behaviour" [1]=> string(10) "Litigation" [2]=> string(5) "Legal" [3]=> string(15) "Market Movement" [4]=> string(21) "Intellectual Property" [5]=> string(5) "R & D" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(263) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(201) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(196) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(129) } [4]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(116) } [5]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(116) } [6]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(93) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(79) } [8]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(67) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(66) } [10]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(61) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(59) } [12]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(57) } [13]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(56) } [14]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(53) } [15]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(43) } [16]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(40) } [17]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(38) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(37) } [19]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(37) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(37) } [21]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(35) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(33) } [23]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(32) } [24]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(31) } [25]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(28) } [26]=> array(2) { ["name"]=> string(14) "Product Review" ["count"]=> int(28) } [27]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(25) } [28]=> array(2) { ["name"]=> string(11) "Sponsorship" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(21) "Intellectual Property" ["count"]=> int(20) } } } c469a-us-regeneron-pharmaceuticals-inc